Evolution Across Europe Europ...

Evolution Across Europe

Europe is getting used to continual change in its pharmaceutical regulation. The plans to update the European Agency for the Evaluation of Medicinal yields (EMEA)--and nearly every aspect of European Union medicines legislation--emerged more clearly during 2002 if it were not that as the year clos the plans were still subordinate to intense discussion, with any possibility of agreement fading into the further reaches of 2003

A larger character for EMEA. As expected, the propos legislative changes included proposals to provide the EMEA with more apts (including those ...